Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 29,000	$ 77,434,000	$ (67,257,000)	$ 10,206,000
Balance (in Shares) at Dec. 31, 2019	29,478,338
Common Stock issued for directors fees		211,000		211,000
Common Stock issued for directors fees (in Shares)	178,405
Costs related to issuance of stock		(145,000)		(145,000)
Issuance of Common Stock	$ 1,000	983,000		984,000
Issuance of Common Stock (in Shares)	419,597
Common Stock Issued for Convertible Notes	$ 2,000	2,587,000		2,589,000
Common Stock Issued for Convertible Notes (in Shares)	1,830,631
Stock Compensation Expense		308,000		308,000
Adjustments for other note conversion		(140,000)		(140,000)
Net Income			1,096,000	1,096,000
Balance at Dec. 31, 2020	$ 32,000	81,238,000	(66,161,000)	15,109,000
Balance (in Shares) at Dec. 31, 2020	31,906,971
Common Stock issued for directors fees		210,000		210,000
Common Stock issued for directors fees (in Shares)	169,811
Stock Options exercised
Stock Options exercised (in Shares)	51,224
Stock Compensation Expense		443,000		443,000
Net Income			1,627,000	1,627,000
Balance at Dec. 31, 2021	$ 32,000	$ 81,891,000	$ (64,534,000)	$ 17,389,000
Balance (in Shares) at Dec. 31, 2021	32,128,006